Xidorin 5 Tablet contains Midodrine 5mg, an alpha-1 adrenergic agonist used primarily for the treatment of symptomatic orthostatic hypotension. Midodrine acts by stimulating alpha-1 adrenergic receptors in the vascular smooth muscle, leading to vasoconstriction and an increase in peripheral vascular resistance, which helps elevate blood pressure upon standing. This pharmacological action makes Xidorin 5 effective in managing conditions characterized by low blood pressure and associated symptoms such as dizziness, lightheadedness, and syncope. The tablet is indicated for patients who experience significant orthostatic hypotension that impairs daily activities and quality of life. Xidorin 5 should be administered under medical supervision with careful dose titration to achieve optimal therapeutic effect while minimizing adverse effects. Common side effects may include piloerection, pruritus, urinary retention, and supine hypertension. It is contraindicated in patients with severe organic heart disease, acute renal disease, urinary retention, and thyrotoxicosis. Monitoring of blood pressure in both supine and standing positions is recommended during treatment. Xidorin 5 Tablet provides a reliable pharmacological option for improving orthostatic tolerance and enhancing patient safety in those affected by chronic hypotensive conditions.